- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech Sustainable Track Record
Chinese Pharmaceuticals & Biotech Sustainable Track Record
UPDATED Apr 12, 2024
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
13 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
2737 | CN¥25.65 | 1.7% | 3.6% | CN¥15.0b | n/a | PE12.4x | n/a | 3.9% | ||
2603 | CN¥19.63 | -3.2% | -36.8% | CN¥32.8b | CN¥27.02 | PE12.1x | E6.8% | 2.5% | ||
600566 | CN¥41.85 | 9.9% | 35.7% | CN¥38.6b | n/a | PE13.7x | E4.8% | 3.1% | ||
301089 | CN¥38.72 | -6.2% | -29.5% | CN¥4.9b | n/a | PE10x | n/a | 1.0% | ||
300896 | CN¥289.86 | -9.4% | -48.0% | CN¥62.4b | CN¥449.26 | PE33.6x | E24.6% | 1.6% | ||
600129 | CN¥32.27 | -0.3% | -25.7% | CN¥18.0b | CN¥52.83 | PE21.9x | E22.9% | 0.9% | ||
915 | CN¥35.80 | -0.9% | -5.7% | CN¥8.4b | n/a | PE14.3x | E13.3% | 5.6% | ||
688278 | CN¥63.20 | -0.8% | 31.7% | CN¥25.7b | n/a | PE46.3x | E26.9% | 0.6% | ||
300705 | CN¥35.12 | -2.9% | 35.3% | CN¥12.1b | n/a | PE32.6x | E25.7% | 0.7% | ||
600976 | CN¥54.17 | -6.6% | -26.0% | CN¥8.2b | CN¥87.74 | PE15.8x | E18.9% | 2.2% | ||
300009 | CN¥9.60 | -3.9% | -19.5% | CN¥16.1b | CN¥19.54 | PE19x | E16.3% | 2.6% | ||
600436 | CN¥216.58 | -6.0% | -23.0% | CN¥130.7b | CN¥293.53 | PE46.9x | E20.3% | 0.6% | ||
300122 | CN¥40.94 | -9.6% | -25.8% | CN¥98.0b | CN¥71.15 | PE11.6x | E19.0% | 0.8% |
Page 1 of 1